Key result
Non-invasive home telemonitoring shows no benefit over standard care for hospitalizations or mortality in decompensated HF.
Why the study?
The study was planned to estimate the effect of non-invasive home telemonitoring in the treatment of patients with recently decompensated heart failure.
Does non-invasive home telemonitoring reduce all-cause hospitalizations and mortality in patients with recently decompensated heart failure?
Comparison
Non-invasive home telemonitoring vs standard care
Design
Systematic review and meta-analysis of randomized controlled studies
Authors
Loading...
No support for routine telemonitoring post-decompensation; confirms neutral impact amid heterogeneity and guides future trial design.
Meta-Analysis (n=4,521)
Does non-invasive home telemonitoring reduce all-cause hospitalizations and mortality in patients with recently decompensated heart failure?
Relative Risk: 0.95 (95% CI 0.84–1.08)
p-value: p=0.43
Non-invasive home telemonitoring does not significantly reduce all-cause hospitalizations or mortality in patients with recently decompensated heart failure, though results are limited by significant clinical heterogeneity among trials.
Drews et al. (2021) conducted a meta-analysis in Recently decompensated heart failure (n=4,521). Non-invasive home telemonitoring vs. Standard care was evaluated on All-cause hospitalizations (RR 0.95, 95% CI 0.84-1.08, p=0.43). Non-invasive home telemonitoring had a neutral effect on all-cause hospitalizations (RR 0.95) and all-cause mortality (RR 0.83) compared to standard care in recently decompensated heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: